✦ LIBER ✦

Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

✍ Scribed by Douglas A. Stewart; Clayton Smith; Ron MacFarland; Gary Calandra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plerixafor in non-Hodgkin’s lymphoma and

✍ Jan S. Moreb 📂 Article 📅 2010 🏛 PAGEPress Publications 🌐 English ⚖ 224 KB

Plerixafor as First- and Second-Line Str

✍ Kevin W. Lor; Pieter J. Helmons; Helen Belew; James R. Lane; Edward D. Ball 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Clonality detection in apheresis product

✍ M.J Araújo; A Carvalhais; A Campos; C.P Vaz; F Campilho; P Pimentel; I.L Barbosa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Expression of CD66 in non-Hodgkin lympho

✍ Karban Josef; Mocikova Heidi; Pytlik Robert; Klener Pavel; Trneny Marek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Expression of CD66 in non-Hodgkin lympho

✍ Barbara-Ann Guinn; Klaus Bosslet; Cindy Lee; Deborah Richardson; Kim Orchard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

288 Pharmacokinetics and pharmacodynamic

✍ F. Sala; E. Marangon; D. Brunelli; C. Sessa; E. Dall'Ó; R. Cereda; V. Livi; M. D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB